79 related articles for article (PubMed ID: 20859808)
1. Methylxanthines and inflammatory cells.
Haskó G; Cronstein B
Handb Exp Pharmacol; 2011; (200):457-68. PubMed ID: 20859808
[TBL] [Abstract][Full Text] [Related]
2. Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritis.
Montesinos MC; Yap JS; Desai A; Posadas I; McCrary CT; Cronstein BN
Arthritis Rheum; 2000 Mar; 43(3):656-63. PubMed ID: 10728760
[TBL] [Abstract][Full Text] [Related]
3. Requirement of intact adenosine A1 receptors for the diuretic and natriuretic action of the methylxanthines theophylline and caffeine.
Rieg T; Steigele H; Schnermann J; Richter K; Osswald H; Vallon V
J Pharmacol Exp Ther; 2005 Apr; 313(1):403-9. PubMed ID: 15590766
[TBL] [Abstract][Full Text] [Related]
4. Methylxanthines in asthma.
Tilley SL
Handb Exp Pharmacol; 2011; (200):439-56. PubMed ID: 20859807
[TBL] [Abstract][Full Text] [Related]
5. Methylxanthines during pregnancy and early postnatal life.
Adén U
Handb Exp Pharmacol; 2011; (200):373-89. PubMed ID: 20859804
[TBL] [Abstract][Full Text] [Related]
6. Involvement of adenosinergic receptors in anxiety related behaviours.
Kulkarni SK; Singh K; Bishnoi M
Indian J Exp Biol; 2007 May; 45(5):439-43. PubMed ID: 17569285
[TBL] [Abstract][Full Text] [Related]
7. Methylxanthine reversal of opioid-evoked inspiratory depression via phosphodiesterase-4 blockade.
Ruangkittisakul A; Ballanyi K
Respir Physiol Neurobiol; 2010 Jul; 172(3):94-105. PubMed ID: 20444435
[TBL] [Abstract][Full Text] [Related]
8. Chronic caffeine or theophylline exposure reduces gamma-aminobutyric acid/benzodiazepine receptor site interactions.
Roca DJ; Schiller GD; Farb DH
Mol Pharmacol; 1988 May; 33(5):481-5. PubMed ID: 2835648
[TBL] [Abstract][Full Text] [Related]
9. Caffeine and theophylline as adenosine receptor antagonists in humans.
Biaggioni I; Paul S; Puckett A; Arzubiaga C
J Pharmacol Exp Ther; 1991 Aug; 258(2):588-93. PubMed ID: 1865359
[TBL] [Abstract][Full Text] [Related]
10. Methylxanthines (caffeine, pentoxifylline and theophylline) decrease the mutagenic effect of daunomycin, doxorubicin and mitoxantrone.
Piosik J; Gwizdek-Wiśniewska A; Ulanowska K; Ochociński J; Czyz A; Wegrzyn G
Acta Biochim Pol; 2005; 52(4):923-6. PubMed ID: 16025164
[TBL] [Abstract][Full Text] [Related]
11. Theophylline inhibits the differentiation of human monocyte into dendritic cell potentially via adenosine receptor antagonism.
Yasui K; Kondo Y; Wada T; Yashiro M; Tsuge M; Morishima T
Clin Exp Allergy; 2009 Dec; 39(12):1857-65. PubMed ID: 20085598
[TBL] [Abstract][Full Text] [Related]
12. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
Chen JF; Chern Y
Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
[TBL] [Abstract][Full Text] [Related]
13. Tricyclic theophylline derivatives with high water-solubility: structure-activity relationships at adenosine receptors, phosphodiesterases, and benzodiazepine binding sites.
Geis U; Grahner B; Pawłowski M; Drabczynska A; Gorczyca M; Müller CE
Pharmazie; 1995 May; 50(5):333-6. PubMed ID: 7604066
[TBL] [Abstract][Full Text] [Related]
14. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
[TBL] [Abstract][Full Text] [Related]
15. Caffeine, theophylline, theobromine, and developmental growth of the mouse mammary gland.
VanderPloeg LC; Wolfrom DM; Rao AR; Braselton WE; Welsch CW
J Environ Pathol Toxicol Oncol; 1992; 11(3):177-89. PubMed ID: 1625188
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline.
Evoniuk G; von Borstel RW; Wurtman RJ
J Pharmacol Exp Ther; 1987 Feb; 240(2):428-32. PubMed ID: 3806407
[TBL] [Abstract][Full Text] [Related]
17. Methylxanthines, inflammation, and cancer: fundamental mechanisms.
Ohta A; Sitkovsky M
Handb Exp Pharmacol; 2011; (200):469-81. PubMed ID: 20859809
[TBL] [Abstract][Full Text] [Related]
18. Methylxanthines and calcium-mobilizing agents inhibit the expression of cytokine-inducible nitric oxide synthase and vascular cell adhesion molecule-1 in murine microvascular endothelial cells.
Bereta M; Bereta J; Georgoff I; Coffman FD; Cohen S; Cohen MC
Exp Cell Res; 1994 Jun; 212(2):230-42. PubMed ID: 7514535
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate and its therapeutic antagonists caffeine and theophylline, target a motogenic T-cell mechanism driven by thrombospondin-1 (TSP-1).
Talme T; Bergdahl E; Sundqvist KG
Eur J Immunol; 2016 May; 46(5):1279-90. PubMed ID: 26909742
[TBL] [Abstract][Full Text] [Related]
20. Is adenosine involved in inhibition of forskolin-stimulated cyclic AMP accumulation by caffeine in rat brain?
Mante S; Minneman KP
Mol Pharmacol; 1990 Nov; 38(5):652-9. PubMed ID: 2172772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]